<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">Plasma will be collected by apheresis from patients recently recovered from laboratory confirmed infection by SARS-CoV-2 (either hospitalised or self-isolated at home) with the following characteristics:
 <list list-type="simple" id="lis0005">
  <list-item id="lsti0005">
   <label>-</label>
   <p id="par0030">at least 14 days from clinical recovery of the patient (no symptoms) and with a negative result of two NAT tests on nasopharyngeal swab and on serum/plasma, performed 24 h apart, following recovery or prior to discharge if hospitalized;</p>
  </list-item>
  <list-item id="lsti0010">
   <label>-</label>
   <p id="par0035">not mandatory (and not required by the majority of protocols in place) is a further negative result of a NAT testing on a nasopharyngeal swab and on serum/plasma, performed 14 days after the first one;</p>
  </list-item>
  <list-item id="lsti0015">
   <label>-</label>
   <p id="par0040">an adequate serum titer of specific neutralizing antibodies (&gt;160 by EIA method or equivalent with other methods, as previously suggested [
    <xref rid="bib0075" ref-type="bibr">[15]</xref>, 
    <xref rid="bib0080" ref-type="bibr">[16]</xref>, 
    <xref rid="bib0085" ref-type="bibr">[17]</xref>]).
   </p>
  </list-item>
 </list>
</p>
